236 related articles for article (PubMed ID: 29036883)
1. MicroRNA-34a: A Versatile Regulator of Myriads of Targets in Different Cancers.
Farooqi AA; Tabassum S; Ahmad A
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036883
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-34a and its target genes: Key factors in cancer multidrug resistance.
Ghandadi M; Sahebkar A
Curr Pharm Des; 2016; 22(7):933-9. PubMed ID: 26648462
[TBL] [Abstract][Full Text] [Related]
3. Alternative mechanisms of miR-34a regulation in cancer.
Slabáková E; Culig Z; Remšík J; Souček K
Cell Death Dis; 2017 Oct; 8(10):e3100. PubMed ID: 29022903
[TBL] [Abstract][Full Text] [Related]
4. Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy.
Gaur S; Wen Y; Song JH; Parikh NU; Mangala LS; Blessing AM; Ivan C; Wu SY; Varkaris A; Shi Y; Lopez-Berestein G; Frigo DE; Sood AK; Gallick GE
Oncotarget; 2015 Oct; 6(30):29161-77. PubMed ID: 26313360
[TBL] [Abstract][Full Text] [Related]
5. The tumor-suppressive and potential therapeutic functions of miR-34a in epithelial carcinomas.
Adams BD; Parsons C; Slack FJ
Expert Opin Ther Targets; 2016 Jun; 20(6):737-53. PubMed ID: 26652031
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of HMGB1 by miR-34a is sufficient to suppress proliferation, migration and invasion of human cervical and colorectal cancer cells.
Chandrasekaran KS; Sathyanarayanan A; Karunagaran D
Tumour Biol; 2016 Oct; 37(10):13155-13166. PubMed ID: 27456356
[TBL] [Abstract][Full Text] [Related]
7. Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells.
Dalgard CL; Gonzalez M; deNiro JE; O'Brien JM
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4542-51. PubMed ID: 19443717
[TBL] [Abstract][Full Text] [Related]
8. microRNA Therapeutics in Cancer - An Emerging Concept.
Shah MY; Ferrajoli A; Sood AK; Lopez-Berestein G; Calin GA
EBioMedicine; 2016 Oct; 12():34-42. PubMed ID: 27720213
[TBL] [Abstract][Full Text] [Related]
9. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.
Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F
Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891
[TBL] [Abstract][Full Text] [Related]
10. Transcriptome-wide characterization of the endogenous miR-34A-p53 tumor suppressor network.
Samuel N; Wilson G; Id Said B; Pan A; Deblois G; Fischer NW; Alexandrova R; Casallo G; Paton T; Lupien M; Gariepy J; Merico D; Hudson TJ; Malkin D
Oncotarget; 2016 Aug; 7(31):49611-49622. PubMed ID: 27391063
[TBL] [Abstract][Full Text] [Related]
11. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
Cheng C; Qin Y; Zhi Q; Wang J; Qin C
Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.
Wu J; Wu G; Lv L; Ren YF; Zhang XJ; Xue YF; Li G; Lu X; Sun Z; Tang KF
Carcinogenesis; 2012 Mar; 33(3):519-28. PubMed ID: 22198213
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-34 and gastrointestinal cancers: a player with big functions.
Gao W; Zhou J; Morshedi M
Cancer Cell Int; 2024 May; 24(1):163. PubMed ID: 38725047
[TBL] [Abstract][Full Text] [Related]
15. miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression.
Corcoran C; Rani S; O'Driscoll L
Prostate; 2014 Sep; 74(13):1320-34. PubMed ID: 25053345
[TBL] [Abstract][Full Text] [Related]
16. Verification of microRNA expression in human endometrial adenocarcinoma.
Jurcevic S; Klinga-Levan K; Olsson B; Ejeskär K
BMC Cancer; 2016 Apr; 16():261. PubMed ID: 27039384
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of microRNAs that synergize with miR-34a - a basis for combinatorial microRNA therapeutics.
Orellana EA; Li C; Lisevick A; Kasinski AL
Cell Cycle; 2019 Aug; 18(15):1798-1811. PubMed ID: 31258013
[TBL] [Abstract][Full Text] [Related]
18. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
Kastl L; Brown I; Schofield AC
Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44.
Yu G; Yao W; Xiao W; Li H; Xu H; Lang B
J Exp Clin Cancer Res; 2014 Dec; 33(1):779. PubMed ID: 25551284
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.
Raver-Shapira N; Marciano E; Meiri E; Spector Y; Rosenfeld N; Moskovits N; Bentwich Z; Oren M
Mol Cell; 2007 Jun; 26(5):731-43. PubMed ID: 17540598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
